- Home
- CNTA vs IIPR Comparison
CNTA vs IIPR Comparison
Compare CNTA & IIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTA
- IIPR
- Stock Information
- Founded
- CNTA 2020
- IIPR 2016
- Country
- CNTA United Kingdom
- IIPR United States
- Employees
- CNTA N/A
- IIPR N/A
- Industry
- CNTA Biotechnology: Pharmaceutical Preparations
- IIPR Real Estate
- Sector
- CNTA Health Care
- IIPR Finance
- Exchange
- CNTA Nasdaq
- IIPR Nasdaq
- Market Cap
- CNTA 2.2B
- IIPR 1.8B
- IPO Year
- CNTA 2021
- IIPR 2016
- Fundamental
- Price
- CNTA $16.63
- IIPR $72.72
- Analyst Decision
- CNTA Strong Buy
- IIPR Buy
- Analyst Count
- CNTA 8
- IIPR 7
- Target Price
- CNTA $23.00
- IIPR $113.20
- AVG Volume (30 Days)
- CNTA 964.8K
- IIPR 258.5K
- Earning Date
- CNTA 03-27-2025
- IIPR 02-19-2025
- Dividend Yield
- CNTA N/A
- IIPR 10.35%
- EPS Growth
- CNTA N/A
- IIPR N/A
- EPS
- CNTA N/A
- IIPR 5.52
- Revenue
- CNTA $6,853,000.00
- IIPR $308,517,000.00
- Revenue This Year
- CNTA N/A
- IIPR N/A
- Revenue Next Year
- CNTA N/A
- IIPR N/A
- P/E Ratio
- CNTA N/A
- IIPR $13.30
- Revenue Growth
- CNTA N/A
- IIPR N/A
- 52 Week Low
- CNTA $7.75
- IIPR $62.45
- 52 Week High
- CNTA $19.09
- IIPR $138.35
- Technical
- Relative Strength Index (RSI)
- CNTA 48.19
- IIPR 47.18
- Support Level
- CNTA $15.50
- IIPR $71.40
- Resistance Level
- CNTA $18.55
- IIPR $75.49
- Average True Range (ATR)
- CNTA 1.25
- IIPR 2.16
- MACD
- CNTA -0.12
- IIPR 0.53
- Stochastic Oscillator
- CNTA 31.57
- IIPR 55.20
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.
About IIPR Innovative Industrial Properties Inc.
Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.